Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Genticel reports additional 12-month data from phase II trial of GTL-001

April 21, 2016

Eiger licenses PEGylated interferon lambda-1a rights from Bristol-Myers Squibb

April 21, 2016

N & N Pharmaceuticals begins phase I trial of N-MCT

April 21, 2016

Bristol-Myers Squibb patents NS5B inhibitors

April 21, 2016

Elbasvir and grazoprevir granted priority review in Japan

April 20, 2016

Arbutus Biopharma presents novel small-molecule inhibitor of HBV capsid assembly

April 20, 2016

BARDA awards contract to Basilea for phase III development of ceftobiprole

April 20, 2016

Assembly Biosciences discloses novel CpAM candidate

April 20, 2016

Protein Sciences, Sinergium Biotech and the Mundo Sano collaborate on Zika vaccine

April 20, 2016

GeoVax gives update on its Zika vaccine program

April 20, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...